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are geographic differences in UHS in Mexican Population. It is 
necessary to investigate the determinant factors of the USS in 
Mexico. 
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Aim of Study: Osteoarthritis (OA) patients (pts) have been re- 
ported to use complementary and alternative medicine (CAM) 
therapies with higher frequency than the general population; how- 
ever, specific information has been scant and comparisons to 
other rheumatic disease patients have not been carried out. This 
pilot study was designed to gather information on CAM use in OA 
pts and to compare them to pts with rheumatoid arthritis (RA) and 
systemic lupus erythematosus (SLE). 
Methods: Questionnaires were mailed to pts seen in the outpa- 
tient practices of an academic medical center with a diagnosis of 
OA, RA or SLE. Data on specific CAM therapies used, reasons 
for use and assessment of efficacy were collected, as well as in- 
formation on health related quality of life (SF-36). 
Results: The response rate was 183/474 (38.6%) total (OA 
88/208 (42%); RA 51/140 (36%); SLE 44/126 (35%)). Overall, 
CAM was used by 65/88 (74%) with OA, 28/51 (55%) with RA 
and 27/44 (61%) with SLE. the most common therapies used by 
each group are listed in the table below. Nutraceutical use was 
substantially more common among, but not unique to, those with 
OA. SLE pts were more likely to use mind-body interventions than 
either arthritis group. Pts used CAM for pain relief: OA: 56/88 
(64%), RA: 21/51 (41%),SLE: 12/44 (27%); for relief of stiffness: 
OA: 48/88 (55%), RA: 21/51 (41%), SLE: 17/44 (39%); for "im- 
mune system problem": OA: 8/88 (10%), RA: 5/51 (10%), SLE: 
9/44 (20%). 
Most Common CAM Therapies By Diagnosis 
OA (n=88) RA (n=51) SLE (n=44) 
glucosamine 39% vitamins 37% vitamins 41% 
chondroitin 38% prayer 24% prayer 30% 
vitamins 36% diet 22% massage 20% 
massage 23% massage 22% diet 18% 
prayer 20% meditation 10% meditation 16% 
diet 14% glucosamine 10% yoga 16% 
chiropractic 11% acupuncture 10% acupuncture 14% 
acunpuncture 10% chondroitin 8% chiropractic 11% 
meditation 7% herbal medicine 8% cognitive therapy 11% 
yoga 6% therapeutic touch 8% imagery 10% 
OA pts were less likely to think CAM was helping them than those 
with RA or SLE. All groups were most likely to think the com- 
bination of CAM and prescription medicines was better than ei- 
ther alone. SF-36 revealed that OA pts scored worse in physical 
functioning and pain than others. OA pts who used CAM plus 
prescription medications had less role limitation due to emotional 
problems than OA pts who used prescribed drugs alone. OA pts 
who used CAM alone scored better in virtually all categories of 
the SF-36 than RA or SLE pts who used CAM alone; OA pts who 
used no medications scored worse in all categories. 
Conclusions: This survey confirms previous studies showing a 
high frequency of CAM use among pts with rheumatic disease, 
regardless of diagnosis. OA pts have the highest rate of use, are 
more likely to be seeking relief of pain and stiffness, and view 
themselves as having more pain and impairment of physical func- 
tioning than pts with RA or SLE. CAM use in OA was correlated 
with better emotional well-being. 
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Objective: To describe the characteristics of the French pa- 
tients with hip osteoarthritis (OA) undergoing total hip arthro- 
plasty (THA). 
Methods: A questionnaire was sent to 1600 general practition- 
ers and 400 rheumatologists. All the practitioners were asked 
to prospectively include one patient with hip OA for whom THA 
was planed to be performed within the next 3 months (population 
1) and/or one patient with hip OA for whom a visit with a sur- 
geon was planed to be performed within the next 3 months to find 
out whether THA was indicated (population 2) and/or one control 
patient with hip OA (population 3). The following variables were 
obtained: age, gender, status regarding work, body mass index 
(BMI), co-morbidities, index hip OA duration, other OA Iocalisa- 
tion, patient's global assessment of OA condition (visual numeric 
scale), WOMAC pain and function subscale scores, New Zealand 
score, quality of life (SF 12 score), patient's expectation regard- 
ing surgery. Additionally, X-rays were obtained, numerized and 
assessed by three independent readers. What follows is a pre- 
sentation and a discussion regarding the results from population 
1. 
Results: Six hundred and eighty five patients for whom THA was 
planed responded to the questionnaire, 529 of them were in- 
cluded by general practitioners and 156 by rheumatologists. The 
mean age of the 685 patients (277 males, 408 females) was 69 
years 4- 9.4, and the mean BMI was 26.3 4- 3.6 kg/m 2. Most were 
retired (82.8%). A significant cardio-vascular disease was present 
in 9.7%, and 1.6% presented with respiratory deficiency. Disease 
duration was 5.4 years 4- 4.2. Hip OA was bilateral in 46.3% of 
the patients, and 52.8% suffered from symptomatic knee OA. The 
mean patient's global assessment of OA condition, WOMAC pain 
and function, New Zealand, and SF 12 physical and mental health 
scores were 7.3 4-1.5, 62.4 4- 13.7, 65 4- 14, 59.9 4- 15.8, 27.2 4- 
5.4, and 41.6 4- 10.8, respectively. Expectations regarding arthro- 
plasty were low (1.2%), intermediate (16.6%) and high (82.2%). 
The Kelgren and Lawrence score of the index hip was 3 or 4 in 
68.6% of patients. 
Conclusion: The demographic haracteristics of French patients 
undergoing THA for hip OA are comparable to those observed 
in other developed countries. The patients frequently experience 
severe pain and are severely disabled, and most present with 
a structurally advanced disease. Major variations in the annual 
THA rates have recently been reported among developed coun- 
tries, France belonging to those with the highest rates. This study 
suggests that differences in THA rates between France and some 
other countries are not due to inter-country differences in the per- 
ception of the level of OA severity at which THA would be appro- 
priate. 
